These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14584215)

  • 1. [New drug class blocks virus-cell fusion. HIV not admitted].
    MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584215
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fusion inhibitors. One year therapy with T-20--initial evaluation].
    Goebel FD
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():42-3. PubMed ID: 15373046
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of virus entry: an antiviral mechanism of emerging prominence.
    Koszalka GW; Meanwell NA
    Curr Opin Investig Drugs; 2006 Feb; 7(2):106-8. PubMed ID: 16499279
    [No Abstract]   [Full Text] [Related]  

  • 4. T-1249 development suspended.
    Huff B
    GMHC Treat Issues; 2003 Dec; 17(12):6. PubMed ID: 15011643
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-HIV agents. Access denied--keeping HIV out with entry inhibitors.
    TreatmentUpdate; 2006; 18(4):4. PubMed ID: 17205653
    [No Abstract]   [Full Text] [Related]  

  • 6. [Strategies for combating resistances in HIV therapy--an exemplifying case].
    Stoehr A
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():70-1. PubMed ID: 15373056
    [No Abstract]   [Full Text] [Related]  

  • 7. Fuzeon combination highly effective.
    AIDS Patient Care STDS; 2006 Dec; 20(12):888. PubMed ID: 17219619
    [No Abstract]   [Full Text] [Related]  

  • 8. Enfuvirtide doubles chances for suppression.
    AIDS Patient Care STDS; 2004 Sep; 18(9):550. PubMed ID: 15630779
    [No Abstract]   [Full Text] [Related]  

  • 9. Katy, bar the door! HIV entry inhibitors.
    Martinez LJ
    Res Initiat Treat Action; 2000 Jun; 6(2):6-12. PubMed ID: 11707878
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials for enfuvirtide (Fuzeon, T-20).
    Crabb C
    AIDS; 2003 Nov; 17(17):N13-4. PubMed ID: 15065580
    [No Abstract]   [Full Text] [Related]  

  • 11. Enfuvirtide (T-20): a novel human immunodeficiency virus type 1 fusion inhibitor.
    Cervia JS; Smith MA
    Clin Infect Dis; 2003 Oct; 37(8):1102-6. PubMed ID: 14523775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion inhibitor trials halted.
    AIDS Patient Care STDS; 2004 Mar; 18(3):182-3. PubMed ID: 15112641
    [No Abstract]   [Full Text] [Related]  

  • 13. Enfuvirtide, the first fusion inhibitor to treat HIV infection.
    Poveda E; Briz V; Soriano V
    AIDS Rev; 2005; 7(3):139-47. PubMed ID: 16302461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enfuvirtide. Two injections per day for HIV].
    Taéron C
    Rev Infirm; 2004 Oct; (104):35-6. PubMed ID: 15581312
    [No Abstract]   [Full Text] [Related]  

  • 15. Virological fitness of HIV in patients with resistance to enfuvirtide.
    Chibo D; Roth N; Roulet V; Skrabal K; Gooey M; Carolan L; Nicholls J; Papadakis A; Birch C
    AIDS; 2007 Sep; 21(14):1974-7. PubMed ID: 17721108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of the clinical development of fusion inhibitor T-1249.
    Martin-Carbonero L
    AIDS Rev; 2004; 6(1):61. PubMed ID: 15168742
    [No Abstract]   [Full Text] [Related]  

  • 17. US FDA approves new class of HIV therapeutics.
    Robertson D
    Nat Biotechnol; 2003 May; 21(5):470-1. PubMed ID: 12721558
    [No Abstract]   [Full Text] [Related]  

  • 18. Enfuvirtide, a new drug for HIV infection.
    Fletcher CV
    Lancet; 2003 May; 361(9369):1577-8. PubMed ID: 12747873
    [No Abstract]   [Full Text] [Related]  

  • 19. [First fusion inhibitor is available. No entry for HIV-1 viruses].
    MMW Fortschr Med; 2003 Jun; 145(25):51. PubMed ID: 12891854
    [No Abstract]   [Full Text] [Related]  

  • 20. Formal approval for Fuzeon.
    AIDS Patient Care STDS; 2004 Dec; 18(12):736. PubMed ID: 15659885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.